Skip to main content Texas-Resilience Against Depression Program Mood Disorders Research Developing a Biosignature for Depression The Texas-Resilience Against Depression (T-RAD) program collects genetic, clinical, demographic, behavioral, and biological information from individuals at risk and those who have been diagnosed with depression or bipolar disorder. Through this 10-year program of 5,000 people, we hope to determine how best to treat and reduce the risk of mood disorders. Not all

Primarily located in the Advanced Imaging Research Center the Corbin Lab routinely utilizes state-of-the–art small animal imaging systems (MRI, micro-MRI, Optical, micro-CT/SPECT/PET) to characterize rodent models of disease.

Trivedi Lab's CTN Big S/W Node

http://www.tandfonline.com/idrt ISSN: 1061-186X (print), 1029-2330 (electronic) J Drug Target, 2015; 23(7–8): 672–680 ! 2015 Taylor & Francis. DOI: 10.3109/1061186X.2015.1073296 REVIEW ARTICLE Nanotechnology-enabled delivery of NQO1 bioactivatable drugs Xinpeng Ma*y, Zachary R. Moore*, Gang Huang, Xiumei Huang, David A. Boothman, and Jinming Gao Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA Abstract

Skip to main content Adolescent Suicide Research Mood Disorders Research Furthering Research into Suicide Prevention Our priorities at the CDRC include studying biomarkers related to youth suicide risk and more effective ways to treat suicidal ideation and behavior. To further this goal of reducing adolescent suicidality, our team has received two grants from the American Foundation for Suicide Prevention (AFSP) and the National Institute of Mental Health (NIMH). Because depression often begins

Meet the Smith Lab team.

Trivedi Lab's Mood Disorders Network

Trivedi Lab's systems

Critical ReviewsTM in Eukaryotic Gene Expression, 24(1):15-28 (2014) 151045-4403/14/$35.00 © 2014 Begell House, Inc. www.begellhouse.com Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases Julio C. Morales,1 Longshan Li,1 Farjana J. Fattah,1 Ying Dong,1 Erik A. Bey,2 Malina Patel,1 Jinming Gao,1 & David A. Boothman1* 1Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75399; 2Department